Utama › Kanser Perut › Texas › Dallas
Kajian klinikal Kanser Perut di Dallas, TX
19 kajian untuk Kanser Perut sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- UT Southwestern, Dallas
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Mengambil pesertaFasa 3
- Baylor Scott & White Health, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
- Baylor, Scott and White Research Institute, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- Texas Oncology - DFW (Sammons CC), Dallas
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Mengambil pesertaFasa 3
- Research Site, Dallas
- Research Site, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Mary Crowley Cancer Research, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- Mary Crowley Cancer Research, Dallas
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Mengambil pesertaFasa 3
- UT Southwestern Medical Center, Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Texas Oncology, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- dan 2 lagi
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Mengambil pesertaFasa 2
- Texas Oncology - DFW, Dallas
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Mengambil pesertaFasa 2
- Texas Oncology Dallas Methodist, Dallas
- Texas Oncology Dallas Medical City, Dallas
- Texas Oncology Dallas Presbyterian, Dallas
- dan 2 lagi
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Mengambil pesertaFasa 1/2
- University of Texas Southwestern Medical Center, Dallas
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Baylor University Medical Center, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Dallas, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Mengambil pesertaFasa 1
- Dren Investigational Site, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Kajian Kanser Perut di bandar lain
- Houston, TX42 kajian
- Boston, MA32 kajian
- New York City, NY31 kajian
- Nashville, TN28 kajian
- Baldwin Park, CA22 kajian
- Los Angeles, CA22 kajian
- Arlington, VA20 kajian
- San Antonio, TX19 kajian
- St. Louis, MO18 kajian
- Grand Rapids, MI18 kajian
- Washington, DC16 kajian
- Chicago, IL16 kajian
Kajian lain di Dallas
- Kanser Payudara55 kajian
- Kanser Paru-paru Bukan Sel Kecil52 kajian
- Kanser Metastatik42 kajian
- Kegagalan Jantung42 kajian
- Kanser (semua jenis)37 kajian
- Kanser Prostat36 kajian
- Kanser Kolorektal33 kajian
- Obesiti30 kajian
- Kanser Ovari28 kajian
- Kanser Paru-paru27 kajian
- Kanser Pundi Kencing27 kajian
- Kanser Endometrium24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.